Stock ELUT ELUTIA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Elutia Inc.

Equities

ELUT

US05479K1060

Market Closed - Nasdaq
Other stock markets
 21:30:01 14/05/2024 BST 		5-day change 1st Jan Change
3.34 USD -2.34% Intraday chart for Elutia Inc. +15.17% +54.63%
05-09 Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-09 Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, vs. Street Est of $6.1M MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Elutia Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Elutia Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Elutia Submits CanGaroo Antibiotic-Eluting Biomatrix for FDA Clearance
Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Berkeley Biologics, LLC completed the acquisition of Orthobiologics business unit of Elutia Inc. for $34.6 million.
Top Premarket Gainers
Wall Street Set to Open Marginally Lower as Fed Kicks Off September Policy Meeting
Equity Futures Trend Higher as Investors Expect No Rate Hike From Fed
Top Premarket Gainers
Elutia Sells Orthobiologics Business Unit For Up to $35 Million
Aziyo Biologics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Aziyo Biologics, Inc. Announces the Voluntary Recall of Its Viable Bone Matrix Products
Aziyo Biologics Says Interim Analysis of CanGaroo Envelope Study Supports Wound-Healing Benefits in Implant Patients
Aziyo Biologics, Inc. Presents Positive Clinical Data on Cangaroo® Biologic Envelope
Aziyo Biologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo's Cardiovascular Portfolio
Aziyo Biologics Signs Distribution Agreement With LeMaitre Vascular for Cardiovascular Portfolio
Aziyo Biologics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
Aziyo Biologics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELUT Stock
  4. News Elutia Inc.
  5. Other languages